Frontlight ResearchEarly access
Trial site
Dana Farber Cancer Center
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia2 trials
- Lung cancer2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Melanoma1 trial
- Multiple myeloma1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 1/23 trials
- Phase 23 trials
- Phase 11 trial
- Phase 31 trial
- Status
- Active, not recruiting4 trials
- Recruiting2 trials
- Terminated2 trials
- Completed1 trial
- Lead sponsor
- Novartis Pharmaceuticals3 trials
- Artios Pharma Ltd1 trial
- CARsgen Therapeutics Co., Ltd.1 trial
- M.D. Anderson Cancer Center1 trial
- Partner Therapeutics, Inc.1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026